Company attributes
B2X
CEO
Founder
Legal Name
Modalis Therapeutics Corporation
Number of Employees (Ranges)
11 – 50
Full Address
700 Main St, Cambridge, Massachusetts, 02139, United States
Investors
Total Funding Amount (USD)
39,064,437
Latest Funding Round Date
April 2019
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Modalis Therapeutics Corporation is developing precision genetic medicines through epigenetic gene modulation. The company is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
